A Colonial home in Weston spanning 8,000 square feet with a carriage house has sold for $8.1 million, the highest in ...

Pending sales jumped more than 7% as buyers returned to Charlotte's housing market in January. But homes are taking longer to ...

At the 2026 State of the Union address, President Donald Trump bragged that he is "ending the wildly inflated cost of prescription drugs." "I got it done under my just-enacted most-favored-nation ...

Weight loss drugmaker Novo Nordisk will cut the list prices of Ozempic and Wegovy by up to 50% beginning in 2027, the company announced on Tuesday. Wegovy currently carries a list price of $1,349 per ...

The list prices of GLP-1 medications like Wegovy and Ozempic are set to fall by up to 50 percent next year following an announcement by pharmaceutical giant Novo ...

Novo Nordisk NOVO.B3.52%increase; green up pointing triangle plans to slash U.S. list prices for its popular weight-loss and diabetes drugs Wegovy and Ozempic by up to half starting next year. Under ...

Novo Nordisk announced Tuesday it will be slashing the list price of its blockbuster GLP-1 medications, Ozempic, Wegovy and Rybelsus, by up to 50 percent beginning next year. Starting on Jan. 1, 2027, ...

Novo Nordisk said Tuesday it will slash its prices for Wegovy and Ozempic beginning next year by up to 50%, highlighting the growing competition among pharmaceutical firms for customers seeking weight ...

Amid efforts on several fronts to improve the affordability of its GLP-1 medications for diabetes and obesity, Novo Nordisk is taking a new approach by aiming straight for semaglutide’s list price.

Novo Nordisk on Tuesday said it plans to slash the monthly list prices of its popular obesity and diabetes drugs in the U.S. by up to 50% starting in 2027. The move aims to make the treatments more ...

A federal judge ruled on Saturday that Kari Lake's leadership of the U.S. Agency for Global Media for much of last year violated federal law, invalidating a sweeping series of actions she took to cut ...

Novo Nordisk announced that it will significantly reduce the U.S. list prices of its widely used weight-loss drugs Wegovy, Ozempic and Rybelsus, starting Jan. 1, 2027. The company said all doses will ...